Thomas B Smith - Net Worth and Insider Trading
Thomas B Smith Net Worth
The estimated net worth of Thomas B Smith is at least $2 Million dollars as of 2024-11-05. Thomas B Smith is the EVP and Chief Medical Officer of Collegium Pharmaceutical Inc and owns about 53,816 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $2 Million. Thomas B Smith is also the Chief Medical Officer of BioDelivery Sciences International Inc and owns about 4,739 shares of BioDelivery Sciences International Inc (BDSI) stock worth over $26,491. Details can be seen in Thomas B Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas B Smith has not made any transactions after 2024-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas B Smith
Thomas B Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas B Smith owns 2 companies in total, including BioDelivery Sciences International Inc (BDSI) , and Collegium Pharmaceutical Inc (COLL) .
Click here to see the complete history of Thomas B Smith’s form 4 insider trades.
Insider Ownership Summary of Thomas B Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BDSI | BioDelivery Sciences International Inc | 2020-01-31 | Chief Medical Officer |
| COLL | Collegium Pharmaceutical Inc | 2024-09-13 | EVP and Chief Medical Officer |
Thomas B Smith Latest Holdings Summary
Thomas B Smith currently owns a total of 2 stocks. Among these stocks, Thomas B Smith owns 53,816 shares of Collegium Pharmaceutical Inc (COLL) as of September 13, 2024, with a value of $2 Million and a weighting of 98.52%. Thomas B Smith also owns 4,739 shares of BioDelivery Sciences International Inc (BDSI) as of January 31, 2020, with a value of $26,491 and a weighting of 1.48%.
Latest Holdings of Thomas B Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2024-09-13 | 53,816 | 32.79 | 1,764,627 |
| BDSI | BioDelivery Sciences International Inc | 2020-01-31 | 4,739 | 5.59 | 26,491 |
Holding Weightings of Thomas B Smith
Thomas B Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas B Smith has made a total of 1 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 9,593 shares on September 13, 2024, which brought Thomas B Smith around $351,296.
According to the SEC Form 4 filings, Thomas B Smith has made a total of 1 transactions in BioDelivery Sciences International Inc (BDSI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BioDelivery Sciences International Inc is the sale of 2,927 shares on January 31, 2020, which brought Thomas B Smith around $15,747.
Insider Trading History of Thomas B Smith
- 1
Thomas B Smith Trading Performance
Thomas B Smith Ownership Network
Ownership Network List of Thomas B Smith
Ownership Network Relation of Thomas B Smith
Thomas B Smith Owned Company Details
What does BioDelivery Sciences International Inc do?
Who are the key executives at BioDelivery Sciences International Inc?
Thomas B Smith is the Chief Medical Officer of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include See Remarks James Vollins , See Remarks Mary Theresa Coelho , and director & Chief Executive Officer Jeffrey Allen Bailey .
BioDelivery Sciences International Inc (BDSI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc (BDSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioDelivery Sciences International Inc Insider Transactions
Thomas B Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas B Smith. You might contact Thomas B Smith via mailing address: Biodelivery Sciences International, Inc., 4131 Parklake Ave Suite 225, Raleigh Nc 27612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
